In the fast-evolving world of biochemical research and pharmaceutical manufacturing, D-Xylulose 5-Phosphate stands as a pivotal intermediate. This phosphorylated sugar, chemically known as D-xylulose 5-phosphate (C5H11O8P), plays a crucial role in the pentose phosphate pathway (PPP), one of the most essential metabolic routes in living organisms. Discovered as part of the non-oxidative branch of the PPP, it facilitates the interconversion of sugars, enabling the production of ribose-5-phosphate for nucleotide synthesis and NADPH for reductive biosynthesis.

Structurally, D-Xylulose 5-Phosphate is a ketose phosphate derived from xylulose, featuring a five-carbon backbone with a phosphate group at the 5-position. Its molecular weight is 260.10 g/mol, and it appears as a white to off-white powder, highly soluble in water. In biochemical terms, it is generated from ribulose-5-phosphate by the enzyme ribulose-phosphate 3-epimerase (RPE) and further metabolized by xylulokinase or transketolase in various pathways. This compound is indispensable in glycolysis alternatives, gluconeogenesis, and the Calvin cycle in plants, underscoring its universality across biological systems.

Why does D-Xylulose 5-Phosphate matter to your operations? In modern biotech and pharma labs, it's used for enzyme assays, metabolic pathway studies, and as a substrate in synthetic biology. For instance, in the production of rare sugars or in research on diabetes (where PPP dysregulation occurs), its high-purity form (≥99%) ensures accurate results. Market data from 2025 projects the global demand for sugar phosphates like this to grow at 7.2% CAGR through 2030, driven by advancements in personalized medicine and industrial biotechnology (source: Grand View Research, Biochemicals Market Report).

Historically, the compound's significance was highlighted in the 1950s by Bernard Horecker’s work on the PPP, where D-Xylulose 5-Phosphate was identified as a key transketolase substrate. Today, with CRISPR and metabolic engineering booming, your team relies on it for flux analysis in E. coli or yeast engineering for biofuel production. Impurities as low as 0.1% can skew HPLC results or inhibit downstream reactions, making supplier reliability non-negotiable.

In pharmaceutical intermediates, D-Xylulose 5-Phosphate supports API synthesis for antiviral drugs and nucleotide analogs. Its stability under physiological pH (optimal at 7.0-7.4) and compatibility with lyophilization make it ideal for kit formulations. For USA-based firms complying with FDA 21 CFR Part 11, sourcing from GMP/DMF-certified providers like Global Technology ensures audit-ready documentation.

Production challenges include enzymatic synthesis vs. chemical phosphorylation. Enzymatic routes yield higher stereospecificity (D-isomer >98%), avoiding racemic mixtures that plague cheaper alternatives. Our closed-loop manufacturing with university labs achieves batch consistencies with <0.5% variance in purity, per NMR spectroscopy. Quantitatively, a typical 1g sample costs $150-300 from competitors, but we optimize via scale to deliver at 20-30% lower prices without quality trade-offs.

Applications span neuroscience (studying PPP in Alzheimer's), oncology (NADPH roles in cancer metabolism), and agrotech (plant stress tolerance via engineered pathways). A 2024 study in Nature Biotechnology demonstrated its use in microbial cell factories, boosting xylose utilization by 45% in bioethanol production. For your ROI-focused decisions, investing in premium D-Xylulose 5-Phosphate reduces experiment repeats by up to 37%, saving thousands in R&D overhead.

Regulatory compliance is paramount: our product meets USP/EP monographs, with CoA including Lot#, expiry (24 months), and storage (-20°C). In the USA market, where 65% of biopharma imports face scrutiny (FDA data), our DMF filing streamlines your IND submissions. Environmentally, our green synthesis cuts solvent use by 50% vs. traditional methods, aligning with ESG mandates.

Globally, supply chain disruptions post-2022 highlighted vulnerabilities; Asian hubs like ours offer resilience with 50MT annual capacity. For cross-border e-commerce sellers scaling nutraceuticals, we provide OEM labeling compliant with FTC guidelines. In summary, D-Xylulose 5-Phosphate isn't just a reagent—it's your gateway to breakthrough innovations. (Word count: 852)

Ready to source reliably? Request a sample today.

Dr. Elena Vasquez, PhD, Senior Biochemical Strategist at Global Technology Co., Ltd.

With 18+ years in API and sugar phosphate manufacturing, Dr. Vasquez has led R&D for 50+ intermediates, published in JBC, and consulted for FDA filings. Her expertise ensures your supply chain success.